Albumin examination can be used to assess short-term glycemic control in certain conditions where HbA1c measurement cannot be applied, such as in patients with type 1 diabetes, type 2 diabetes receiving insulin therapy, hemolytic anemia, bleeding, blood transfusion, chronic kidney failure undergoing hemodialysis, pregnant women, liver cirrhosis, variant hemoglobin, and patients with postprandial hyperglycemia [68]. The gene discussed is ALB; the disease is cirrhosis of liver.